Cargando…

Mutation analysis of BRAF and KIT in circulating melanoma cells at the single cell level

BACKGROUND: The availability of molecular-targeted therapies for the treatment of melanoma has emphasised the need to identify mutations in target genes such as BRAF and KIT. Circulating tumour cells (CTC) are present in the peripheral blood of a significant proportion of cancer patients. METHODS: H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakaizawa, K, Goto, Y, Kiniwa, Y, Uchiyama, A, Harada, K, Shimada, S, Saida, T, Ferrone, S, Takata, M, Uhara, H, Okuyama, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305957/ https://www.ncbi.nlm.nih.gov/pubmed/22281663 http://dx.doi.org/10.1038/bjc.2012.12

Ejemplares similares

Polyclonality of BRAF mutations in primary melanoma and the selection of mutant alleles during progression
por: Lin, J, et al.
Publicado: (2011)

BRAF Mutation Heterogeneity in Melanoma Lesions
por: SAKAIZAWA, Kaori, et al.
Publicado: (2020)

BRAF(V600E) protein expression and outcome from BRAF inhibitor treatment in BRAF(V600E) metastatic melanoma
por: Wilmott, J S, et al.
Publicado: (2013)

Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas
por: Satzger, I, et al.
Publicado: (2008)

BRAF(V600E) melanoma cells secrete factors that activate stromal fibroblasts and enhance tumourigenicity
por: Whipple, C A, et al.
Publicado: (2014)

Mutation landscape in melanoma patients clinical implications of heterogeneity of BRAF mutations
por: Heinzerling, L, et al.
Publicado: (2013)

Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study
por: Board, R E, et al.
Publicado: (2009)

Circulating microRNAs as biomarkers for early detection of diffuse-type gastric cancer using a mouse model
por: Rotkrua, P, et al.
Publicado: (2013)

Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS
por: Zuidervaart, W, et al.
Publicado: (2005)

BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer
por: Yokota, T, et al.
Publicado: (2011)

Usefulness of monitoring circulating tumor cells as a therapeutic biomarker in melanoma with BRAF mutation
por: Kiniwa, Yukiko, et al.
Publicado: (2021)

BRAF-V600E expression in primary nodular melanoma is associated with aggressive tumour features and reduced survival
por: Hugdahl, Emilia, et al.
Publicado: (2016)

Prognostic significance of CD45RO+ memory T cells in renal cell carcinoma
por: Hotta, K, et al.
Publicado: (2011)

Circulating cell-free miRNAs as biomarker for triple-negative breast cancer
por: Shin, V Y, et al.
Publicado: (2015)

BRAF(V600E) mutation in anaplastic thyroid carcinomas and their accompanying differentiated carcinomas
por: Takano, T, et al.
Publicado: (2007)

Clinical significance of CDX2-positive circulating tumour cells in colorectal cancer patients
por: Wong, S C C, et al.
Publicado: (2011)

Monitoring gastric cancer progression with circulating tumour DNA
por: Hamakawa, T, et al.
Publicado: (2015)

Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer
por: Ino, Y, et al.
Publicado: (2013)

A UK feasibility and validation study of the VE1 monoclonal antibody immunohistochemistry stain for BRAF-V600E mutations in metastatic melanoma
por: Lo, Michelle Chin I, et al.
Publicado: (2016)

Circulating tumour cell-derived plastin3 is a novel marker for predicting long-term prognosis in patients with breast cancer
por: Ueo, H, et al.
Publicado: (2015)

RET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysis
por: Tsuta, K, et al.
Publicado: (2014)

Circulating cell-free DNA as a predictive marker for distant metastasis of hepatitis C virus-related hepatocellular carcinoma
por: Tokuhisa, Y, et al.
Publicado: (2007)

CTGF is overexpressed in malignant melanoma and promotes cell invasion and migration
por: Braig, S, et al.
Publicado: (2011)

A loss of c-kit expression is associated with an advanced stage and poor prognosis in breast cancer
por: Tsutsui, S, et al.
Publicado: (2006)

Increased mobilisation of circulating endothelial progenitors in von Hippel-Lindau disease and renal cell carcinoma
por: Bhatt, R S, et al.
Publicado: (2011)

Protumoral roles of melanoma inhibitory activity 2 in oral squamous cell carcinoma
por: Kurihara, M, et al.
Publicado: (2013)

Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype
por: Ameri, K, et al.
Publicado: (2010)

Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancer
por: Nonomura, N, et al.
Publicado: (2007)

Detection of circulating tumour cells in peripheral blood with an automated scanning fluorescence microscope
por: Ntouroupi, T G, et al.
Publicado: (2008)

Flexible, actin-based ridges colocalise with the β1 integrin on the surface of melanoma cells
por: Poole, K, et al.
Publicado: (2005)

Cell-free and cell-bound circulating DNA in breast tumours: DNA quantification and analysis of tumour-related gene methylation
por: Skvortsova, T E, et al.
Publicado: (2006)

Malignant melanoma and bone resorption
por: Lau, Y S, et al.
Publicado: (2006)

Significance of nerve growth factor overexpression and its autocrine loop in oesophageal squamous cell carcinoma
por: Tsunoda, S, et al.
Publicado: (2006)

A novel AKT3 mutation in melanoma tumours and cell lines
por: Davies, M A, et al.
Publicado: (2008)

Monitoring of circulating tumour-associated DNA as a prognostic tool for oral squamous cell carcinoma
por: Hamana, K, et al.
Publicado: (2005)

FADD phosphorylation is critical for cell cycle regulation in breast cancer cells
por: Matsuyoshi, S, et al.
Publicado: (2006)

Increased circulating cell signalling phosphoproteins in sera are useful for the detection of pancreatic cancer
por: Takano, S, et al.
Publicado: (2010)

Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma
por: Komatsu, S, et al.
Publicado: (2011)

KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West: Results from a large international multicentre study
por: van Grieken, N C T, et al.
Publicado: (2013)

Circulating tumour cells in the central and the peripheral venous compartment in patients with metastatic breast cancer
por: Peeters, D J E, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ht840i4m1vlsj38hrk92k7eohi